Showing results (1-10 of 89) with videos related to
Sort By:
Pageof 9
Oncotargets and Therapy|November 19, 2020
Overexpression of GIHCG is Associated with a Poor Prognosis and Immune Infiltration in Hepatocellular CarcinomaSiyu Xiao, Shanzhou Huang, Jie YangCell Death and Differentiation|August 14, 2024
AMDHD1 acts as a tumor suppressor and contributes to activation of TGF-β signaling pathway in cholangiocarcinomaZuyi Ma, Jia Sun, Zhenchong Li, et al.Cancer Cell International|October 16, 2020
A four prognosis-associated lncRNAs (PALnc) based risk score system reflects immune cell infiltration and predicts patient survival in pancreatic cancerHongkai Zhuang, Shanzhou Huang, Zixuan Zhou, et al.Annals of Medicine|September 12, 2024
What eliminates the chance for cure: a multi-center evaluation on 10-year follow-up of gallbladder cancer after surgical resectionZuyi Ma, Zhenchong Li, Jiasheng Cao, et al.Frontiers in Molecular Biosciences|April 20, 2026
Revealing the role of a novel IDS gene mutation in mucpolysaccharidosis type II: insights from computational analysisShanzhou Huang, Chonghan Li, Yuyuan Zhi, et al.Biochemical and Biophysical Research Communications|May 8, 2016
High expression of hexokinase domain containing 1 is associated with poor prognosis and aggressive phenotype in hepatocarcinomaZijian Zhang, Shanzhou Huang, Huanyu Wang, et al.Cancer Cell International|November 22, 2025
Ammonia in cancer: dual roles and therapeutic strategiesJinhui Wei, Yue Chen, Quanzhang Li, et al.Cancer Immunology, Immunotherapy : CII|July 19, 2021
Identification of LIPH as an unfavorable biomarkers correlated with immune suppression or evasion in pancreatic cancer based on RNA-seqHongkai Zhuang, Xinming Chen, Ying Wang, et al.BMC Cancer|May 4, 2023
Identification of SPRYD4 as a tumour suppressor predicts prognosis and correlates with immune infiltration in cholangiocarcinomaZuyi Ma, Tiange Xie, Jia Sun, et al.Human Pathology|August 24, 2018
Elevated DSN1 expression is associated with poor survival in patients with hepatocellular carcinomaChengjun Sun, Shanzhou Huang, Weiqiang Ju, et al.Pageof 9